Blue dye may prevent dialysis danger in ICU patients
NCT ID NCT05092165
First seen Apr 23, 2026 · Last updated May 13, 2026 · Updated 2 times
Summary
This study tested whether methylene blue, a medicine that affects blood vessel tone, can prevent low blood pressure during kidney dialysis in critically ill patients. 261 adults with acute kidney injury and low blood pressure or requiring blood pressure support took part. The goal was to see if methylene blue reduces the need for extra blood pressure medication or prevents dialysis interruptions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Federal University of São Paulo
São Paulo, São Paulo, 04038002, Brazil
Conditions
Explore the condition pages connected to this study.